| Effectiveness of bivalent boosters against severe omicron infection DY Lin, Y Xu, Y Gu, D Zeng, B Wheeler, H Young, SK Sunny, Z Moore New England Journal of Medicine 388 (8), 764-766, 2023 | 187 | 2023 |
| Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes DY Lin, Y Gu, Y Xu, B Wheeler, H Young, SK Sunny, Z Moore, D Zeng Jama 328 (14), 1415-1426, 2022 | 105 | 2022 |
| Durability of bivalent boosters against Omicron subvariants DY Lin, Y Xu, Y Gu, D Zeng, SK Sunny, Z Moore New England Journal of Medicine 388 (19), 1818-1820, 2023 | 79 | 2023 |
| Effects of vaccination and previous infection on omicron infections in children DY Lin, Y Gu, Y Xu, D Zeng, B Wheeler, H Young, SK Sunny, Z Moore New England Journal of Medicine 387 (12), 1141-1143, 2022 | 54 | 2022 |
| Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort … DY Lin, Y Xu, Y Gu, D Zeng, B Wheeler, H Young, Z Moore, SK Sunny The Lancet Infectious Diseases 23 (11), 1257-1265, 2023 | 18* | 2023 |
| Marginal proportional hazards models for multivariate interval-censored data Y Xu, D Zeng, DY Lin Biometrika 110 (3), 815-830, 2023 | 3 | 2023 |
| Durability of XBB. 1.5 Vaccines against Omicron Subvariants DY Lin, Y Du, Y Xu, S Paritala, M Donahue, P Maloney New England Journal of Medicine, 2024 | 2 | 2024 |
| Proportional rates models for multivariate panel count data Y Xu, D Zeng, DY Lin Biometrics 80 (1), ujad011, 2024 | 1 | 2024 |
| Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and death DY Lin, Y Xu, Y Gu, SK Sunny, Z Moore, D Zeng International Journal of Infectious Diseases 145, 107084, 2024 | | 2024 |
| Effectiveness of XBB. 1.5 Vaccines Against Omicron Subvariants D Lin, Y Du, Y Xu, S Paritala, M Donahue, P Maloney medRxiv, 2024.07. 01.24309806, 2024 | | 2024 |
| Statistical Methods for Analyzing Interval-Censored Data Y Xu | | 2024 |
| Effectiveness of Bivalent Boosters Over Nine and Half Months S Paritala, Y Xu, Y Du, M Donahue, P Maloney, DY Lin Journal of Biotechnology and Biomedicine 6 (4), 585-589, 2023 | | 2023 |
| A Cost-Benefit Analysis of Bivalent Covid-19 Vaccines DY Lin, Y Xu, D Zeng, SK Sunny Journal of biotechnology and biomedicine 6 (4), 551, 2023 | | 2023 |
D. Y. (Danyu) LinUniversity of North Carolina at Chapel Hill在 bios.unc.edu 的电子邮件经过验证
